Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a gel stop genital warts from coming back?

NCT ID NCT07698886

Recruiting now Disease control Sponsor: KTH Biopharma Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This phase 2 trial tests whether applying a special gel (Geniwa gel) after laser removal can better treat recurrent genital warts and prevent them from returning. Adults who have had at least three laser treatments and still experience recurrences are eligible. Participants receive either the active gel or a placebo gel alongside laser treatment, and are monitored for wart clearance and recurrence over several months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Geniwa gel (alpha lactalbumin-oleic acid 5%)
What this could lead to
If effective, this combination could offer a way to clear recurrent genital warts and lower the chance of them coming back.
What could go wrong
This is a mid-stage trial with only 70 participants, so results may not apply to everyone. The gel may cause side effects or fail to outperform placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENITAL WARTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anogenital human papillomavirus infection human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GENITAL WARTS HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Dermatology Hospital, Hanoi, Vietnam.

    RECRUITING

    Hanoi, None (International), 121000, Vietnam

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.